-+ 0.00%
-+ 0.00%
-+ 0.00%

Evaxion A/S Announces Expansion of AI-Immunology™ Platform Into Autoimmune Diseases and Outlines 2026 Milestones Including Biomarker Data, Clinical Efficacy Results, and Pipeline Advancements

Reuters·01/13/2026 13:00:53

Please log in to view news